MyLymphomaTeam

Splenic Marginal Zone Lymphoma (SMZL) is a rare, slow-growing type of non-Hodgkin lymphoma that makes up about 1-2% of all NHL cases. It mainly affects the spleen and blood, and because it grows slowly, many people live with it for years. Symptoms

Not everyone has symptoms right away — about 1 in 4 people don't notice Show Full Answer

Splenic Marginal Zone Lymphoma (SMZL) is a rare, slow-growing type of non-Hodgkin lymphoma that makes up about 1-2% of all NHL cases. It mainly affects the spleen and blood, and because it grows slowly, many people live with it for years. Symptoms

Not everyone has symptoms right away — about 1 in 4 people don't notice anything early on. When symptoms do appear, they can include:

- An enlarged spleen, causing abdominal pain or fullness
- Feeling full quickly after eating
- Fatigue, shortness of breath (if anemia develops)
- Fever, night sweats, and weight loss (known as "B symptoms")
- Bruising or bleeding issues due to low platelet counts Treatment Options

There's no single standard treatment — doctors tailor plans based on symptoms and overall health. Options include:

- Watch and wait — if there are no symptoms, treatment may not be needed right away
- Rituximab (Rituxan) — the most common first-line targeted therapy, less toxic than chemo
- Rituximab + chemotherapy — sometimes combined for stronger effect
- Splenectomy — surgical removal of the spleen, though less common now
- BTK inhibitors (e.g., ibrutinib, acalabrutinib, zanubrutinib) — used if lymphoma returns or stops responding to treatment
- Chemotherapy — still an option but used less often due to higher toxicity Outlook

SMZL currently cannot be cured, but many people are successfully managed with treatment. The 5-year survival rate is around 77%, and the 10-year rate is about 60%. It does tend to relapse over time, so regular monitoring with your healthcare team is really important.

Factors that may affect outlook include older age, enlarged lymph nodes, certain gene mutations, and low blood cell counts — so staying in close contact with your doctor helps ensure any changes are caught early.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Splenic Marginal Zone Lymphoma: Prognosis, Symptoms, and More